PLEASANTON, Calif., Oct. 11, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company will release its 2017 third quarter financial results before the market opens on Wednesday, October 25th. Natus management will host an investment-community conference call the same day beginning at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing 1-844-634-1441 for domestic callers, or 1-508-637-5658 for international callers, and entering reservation code 79380520. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-855-859-2056 for domestic callers, or 1-404-537-3406 for international callers, and entering reservation code 79380520.
The conference call also will be available real-time via the Internet at http://investor.natus.com and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.
About Natus Medical Incorporated
Natus is a leading provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, neurosurgery, epilepsy, sleep disorders, and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT:
Natus Medical Incorporated
Jonathan A. Kennedy
Executive Vice President and Chief Financial Officer
(925) 223-6700
[email protected]


BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
Baker Hughes Sells Waygate Technologies to Hexagon for $1.45 Billion
Chinese Cars in Europe: Consumer Trust Is Shifting Fast
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Volkswagen Q1 2026 Sales Decline Amid China and U.S. Market Pressures 



